CMIC Holdings Co Ltd (2309):製薬・医療:M&Aディール及び事業提携情報

GlobalDataが発行した調査報告書(DATA904C3491)
◆英語タイトル:CMIC Holdings Co Ltd (2309) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3491
◆発行会社(リサーチ会社):GlobalData
◆発行日:2018年8月
◆ページ数:37
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
CMIC Holdings Co Ltd (CMIC) is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, registration, eclinical trials, quality management, quality assurance, pharmacovigilance and medical writing. CMIC also offers development and marketing of biomarkers, orphan drugs and clinical trials systems. The organization’s healthcare business includes system development and clinical research disease control services. It has offices in Tokyo, Nagoya, Osaka and Kyushu. CMIC is headquartered in Minato-Ku, Tokyo, Japan.

CMIC Holdings Co Ltd (2309) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
CMIC Holdings Completes Acquisition Of CRO Business From Nihon Ultmarc 10
CMIC CMO Completes Acquisition Of Research Equipment From Daiichi Sankyo 11
Partnerships 12
CMIC Enters and Fosun Pharma Enter into Joint Venture Agreement 12
CMIC Enters into Agreement with MSD for Diazoxide 13
Medinet Partners with CMIC Holdings 14
CMIC Holdings and ShiftZero Form Joint Venture 15
UDG Healthcare Forms Joint Venture with CMIC 16
CMIC Forms Joint Venture With Medipal For Orphan Drugs 17
Equity Offering 18
CMIC CMO to Raise USD80 Million in Private Placement of Shares 18
Acquisition 19
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 19
CMIC Holdings Acquires Pharma Company from Mitsubishi Tanabe Pharma for USD32.2 Million 21
McCann Healthcare Acquires 51% Stake In MDS 22
CMIC Holdings Co Ltd – Key Competitors 23
CMIC Holdings Co Ltd – Key Employees 24
CMIC Holdings Co Ltd – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Joint Venture 26
Recent Developments 27
Strategy And Business Planning 27
Jul 27, 2018: Notice concerning integration of consolidated subsidiaries of CRO business 27
Financial Announcements 28
Jul 27, 2018: CMIC HOLDINGS releases consolidated financial results for the 3rd quarter ended June 30, 2018 28
Apr 27, 2018: CMIC HOLDINGS Consolidated Financial Results 31
Corporate Communications 34
Feb 01, 2018: CMIC HOLDINGS Announces Change of President 34
Government and Public Interest 35
Jun 06, 2018: CMIC participated in 2018 ASCO Annual Meeting 35
Other Significant Developments 36
Feb 01, 2018: CMIC Holdings: Integration of Consolidated Subsidiaries of CRO Business 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMIC Holdings Co Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CMIC Holdings Completes Acquisition Of CRO Business From Nihon Ultmarc 10
CMIC CMO Completes Acquisition Of Research Equipment From Daiichi Sankyo 11
CMIC Enters and Fosun Pharma Enter into Joint Venture Agreement 12
CMIC Enters into Agreement with MSD for Diazoxide 13
Medinet Partners with CMIC Holdings 14
CMIC Holdings and ShiftZero Form Joint Venture 15
UDG Healthcare Forms Joint Venture with CMIC 16
CMIC Forms Joint Venture With Medipal For Orphan Drugs 17
CMIC CMO to Raise USD80 Million in Private Placement of Shares 18
JSR Corporation, CMIC Holdings and INCJ to Acquire KBI Biopharma 19
CMIC Holdings Acquires Pharma Company from Mitsubishi Tanabe Pharma for USD32.2 Million 21
McCann Healthcare Acquires 51% Stake In MDS 22
CMIC Holdings Co Ltd, Key Competitors 23
CMIC Holdings Co Ltd, Key Employees 24
CMIC Holdings Co Ltd, Other Locations 25
CMIC Holdings Co Ltd, Subsidiaries 25
CMIC Holdings Co Ltd, Joint Venture 26

List of Figures
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CMIC Holdings Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ CMIC Holdings Co Ltd (2309):製薬・医療:M&Aディール及び事業提携情報(CMIC Holdings Co Ltd (2309) - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆